WuXi Biologics (02269.HK) has cancelled a total of 60,539,500 repurchased shares.

China Fortune Financial News APP, WuXi Biologics (02269.HK) announced that on May 8, 2025, it issued 70,000 ordinary shares for the exercise of options under the first public offering pre-subscription plan adopted by the company on January 5, 2016 (revised on August 10, 2016).